ABSTRACT. L-histidine is an essential amino acid. Its fetal-to-maternal blood concentration ratio is high, suggesting active placental transport. In this study, human placental microvillous membrane vesicles were used to characterize L-histidine transport, heretofore not evaluated in human tissue. L-Histidine uptake by microvillous membrane vesicles was stimulated by an inward sodium gradient, leading to an "overshoot," followed by apparent equilibration. Linear uptake at 22" C was limited to the 1st min. The initial sodium-dependent uptake rate was proportional to the sodium concentration in the medium. The sodium-dependent uptake was markedly diminished or lost when potassium, cesium, or choline was substituted for sodium but not lithium. Replacement of chloride with sulfate or gluconate had little effect. Sodium-stimulated Lhistidine uptake was further stimulated by an outward potassium gradient (inside-negative) in the presence of valinomycin. Sodium-dependent uptake kinetic constants for L-histidine were: Km = 0.44 f 0.18 mM: V,,, = 536 f 94 nmol/mg/30 s (mean f SD). 2-(methylamino)isobutyric acid did not inhibite L-histidine uptake. Conversely, L-histidine noncompetitively inhibited sodium-dependent uptake of 2-(methylamino)isobutyric acid and Lcysteine. L-glutamine competitively inhibited sodium-dependent L-histidine uptake. L-histidine uptake was stimulated by preloading the vesicles with either L-histidine or L-glutamine (transstimulation). L-histidine uptake was not sensitive to N-ethylmaleimide treatment but was strongly inhibited by low pH. These findings suggest that L-histidine is transported in the human placenta by a specific sodium-dependent system similar to the "N" system described in rodent hepatocytes. Furthermore, the ready availability of placental tissue may make it a useful resource for studies of human epithelial transport biology. (Pediatr Res 25:19-26, 1989) Abbreviations MeAIB, 2-(methy1amino)isobutyric acid MMV, microvillous membrane vesicles HTM solution, 10 mM HEPES-Tris buffer, pH 7.4, with 300 mM mannitol
recipient of Research Scientist Development Award AA00074. 1 placenta transfers amino acids to the fetus (I), with uptake occurring at the microvillous membrane. Isolation of human placental MMV was originally described by Smith et al. (2) .
MMV preparations permit studies of membrane-associated transport without certain confounding variables, such as intracellular metabolism, and are restricted to a specific region of the cell surface. Basic measurements have been made for the uptake of some amino acids by human placental MMV (3) (4) (5) (6) (7) (8) , but no analyses have been performed on the essential amino acid, histidine. We report here several parameters of human placental MMV uptake of L-histidine, an important amino acid for which transport characteristics have been described only in nonplacental animal tissue. L-Histidine is an essential amino acid in humans (9) , being of particular importance during periods of rapid growth (10) . It is a precursor in the process of folate-dependent DNA synthesis (9) , and its potential importance for fetal development is reflected in the steep fetal-to-maternal concentration ratio in blood (I).
L-histidine transport is thought to occur by a relatively specific, sodium-dependent, membrane-associated mechanism or "system." However, the " N system for L-histidine has only been demonstrated in nonplacental animal tissue, particularly rat hepatocytes (1 I). We have used several parameters characteristic of the rodent hepatocyte system N to examine L-histidine uptake by human placental MMV. MMV preparation. The placentas were obtained immediately after either cesarean or vaginal delivery. MMV were prepared by a modification (12) of the method of Smith et al. (2) . Briefly, the placentas from normal term delivery (37-40 wk gestation) were placed in ice-cold saline and processed immediately. Both the maternal decidual and fetal membranes were removed, and blood vessels were carefully dissected away. A total of 100-1 50 g of tissue was washed with HTM solution. Washed tissue fragments were placed in 300 ml of HTM solution and stirred with a magnetic stirrer (70 rpm) for 30 min at 4" C. The suspension was filtered through six layers of cheesecloth, and the filtrate was centrifuged for 10 min at 10,000 x g to remove debris. The supernatants were combined, mixed, and centrifuged 9 for 30 rnin at 105,000 x g. The pellets were combined and resuspended in HTM solution using a loose-fitting Dounce homogenizer. Concentrated MgClz solution (1 M) was added to a final concentration of 10 mM. The preparation was mixed thoroughly, placed on ice for 10 rnin and centrifuged at 3000 x g for 15 rnin to remove non-MVM. The supernatant was centrifuged for 30 min at 105,000 x g. MgCl was removed by washing the pellet twice and resuspending in HTM solution with a loosefitting Dounce homogenizer. The suspension was centrifuged for 30 rnin at 105,000 x g. The final pellet was suspended in HTM solution to a final protein concentration of 5-7 mg/ml after passing it 20 times through a 25 gauge needle. Using this method, 100-g tissue fragments resulted in about 30 mg of MMV protein.
MATERIALS AND METHODS

Materials
The vesicle preparation was stored at 2" C for transport studies and at -80" C for enzyme analyses. Our preliminary studies showed that freezing at -80" C greatly reduces sodium-stimulated histidine transport by MMV. However, transport activity is unaffected for at least 4 days when stored at 2" C. All transport studies used the vesicles within 3 days of preparation.
Uptake experiments. Uptake was determined by adding the MMV preparation to the incubation medium containing radiolabeled substrates and various ions (see text, tables, or figure legends for specific compositions which varied with experimental purpose). Usually, the MMV preparation was added to the incubation medium in a ratio of 1:4 (vo1:vol) except for the pH study, which was 1:9) at 22" C. After incubation, 50 p1 of the mixture was rapidly filtered by negative pressure through prewetted nitrocellulose filters (Millipore Continental Water Systems, Bedford, MA, or Gelman Sciences, Inc., Ann Arbor, MI: pore size 0.45 pm) and washed four times with 4 ml of ice-cold incubation buffer. This process was completed within 10 s. The filters were dissolved in 2 ml Cellosolve (Fisher Scientific, Springfield, NJ) and 10 ml Liquiscint (National Diagnostic, Manville, NJ) were added before determining radioactivity in a Packard Tricarb Scintillation Analyzer 2000CA (Hewlett Packard Co., Palo Alto, CA). Samples for each data point were evaluated at least in triplicate. Nonspecific binding of radioactivity to the filter was less than 0.02% of the total radioactivity applied to the filter. This background activity was subtracted from uptake data.
The effect of electrical potential on sodium stimulated Lhistidine uptake was determined using vesicles prepared in 100 mM potassium gluconate, 100 mM mannitol, and 10 mM HEPES-Tris buffer. These vesicle were incubated with the potassium ionophore, valinomycin (12.5 pg/mg protein), for 30 rnin at 37" C. Enhanced electrical potential was generated by diluting the vesicle into solution containing 50 mM sodium chloride, 200 mM mannitol, and HEPES-Tris buffer which contained 100 pM radioactive L-histidine. Control uptake was measured in buffer containing 50 mM sodium chloride, 100 mM potassium gluconate, and HEPES-Tris buffer.
Enzyme assay. Alkaline phosphatase was determined by the liberation of p-nitrophenol from p-nitrophenol phosphate in 50 mM glycine/NaOH buffer (pH 10.5) in the presence of 0.5 mM MgCl2 (sigma Technical Bulletin 104). 5'-nucleotidase was assayed with AMP as the substrate in 50 mM Tris/HCl buffer, pH 8.5 (Sigma Technical Bulletin 675). The liberated phosphate was determined colorirnetrically by the method of Chen et al. (13) . Na+/Kf-ATPase was determined by the method of Marks and Seeds (14) , wherein ATP is regenerated to avoid product inhibition. To this reaction mix, NaN3 is added to reduce activity of nonspecific phosphatases (1 5) . The assay contained 40 mM Tris-HC1, pH 4, with 100 mM NaCl, 15 mM NaN3, 20 mM KCl, 3 mM MgC12, 0.5 mM EDTA, 3 mM ATP, 1.5 mM phospho(eno1)pyruvate and 10 U of pyruvate kinase; +1 mM ouabain. Na+/K+-ATPase activity was determined as the ouabainsensitive production of phosphate from ATP at 37" C over a 20-rnin period. Protein was determined by the method of Markwell et al. (16) , a modification of the original method of Lowry et al.
( 1 7). This method allows assay of protein in the presence of high lipid concentration.
Data expression. Data are represented as mean f SD and analyzed by the t test for paired data or by ANOVA. Differences between group means were considered significant for p < 0.05.
The least squares method (Statgraphics) was used to obtain the best fitting lines for analysis of uptake kinetics.
RESULTS and DISCUSSION
Characterization of MMV preparation. 5'-Nucelotidase and alkaline phosphatase, enzymes known to be present in the microvillous membrane were enriched greater than 49-and 27-fold, respectively, in all preparations (5' -nucleotidase: homogenate = 3.3 + 1.4 (mean +: SD); vesicle preparation = 162 + 43 pmol Pi. mg-I . min-I; alkaline phosphatase: homogenate = 0.13 + 0.04; vesicle preparation = 3.38 + 0.79p nmol p-nitrophenyl. mg-'.min-'). The activity of Na+/K+-ATPase was slightly enriched in these preparations (homogenate = 66 ? 27; vesicle = 563 k 1 18 nmol P,. mg-I. 20 min-I). These data are similar to an earlier observation (18) which showed an enrichment of approximately 6-fold of Na+/Kf-ATPase activity in MMV preparations. As they explained, the modest increase in Na+/K+-ATPase activity may be due to the fact that the placenta consists of structures which are mostly devoid of Naf/K+-ATPase. Therefore, the whole tissue homogenate is relatively low in activity, making detection difficult, and the slightest contamination during purification could result in apparent enrichment.
Transmission electron microscopy of vesicle preparations (not shown) revealed closed vesicular structures with absence of any identifiable organelles. Treatment of the MMV with 1 % Triton X-100 increased the alkaline phosphatase activity by only 6% (control = 4.63 + 0.01; Triton treated = 5.17 + 0.02 pmol.
mg-'.min-'), indicating that the vast majority of the vesicles were facing right side out (3).
The intravesicular space was measured as described by Kletzien et al. (19) ). An explanation for these differences is not immediately apparent. Uptake of L-histidine was linear over a range of vesicle protein concentration: 20-100 pg/50 pl reaction. All subsequent uptake experiments were carried out using 50-60 pg of vesicle protein in 50 p1 incubation vol.
Effect of osmolarity and temperature on L-histidine transport.
To demonstrate that the apparent uptake of radioactive amino acid represents translocation into the intravesicular space, sensitivity of L-histidine uptake to changes in the osmolarity of the uptake medium was determined. Osmolarity of the medium was changed by varying the concentration of sucrose, a relatively impermeable solute. Increasing medium osmolarity decreases intravesicular space (20) . A plot of uptake versus l/osmolarity yielded linear line (r = 0.992) with y-intercept of 78.1 pmol . mg protein-' which is 26.5% of uptake at the standard osmolarity of 300 (295 pmol. mg protein-'). The radioactivity associated with the vesicles was inversely proportional to osmolarity. The results indicate that the L-histidine uptake measurements represents entry of the amino acid into a changing MMV space, rather than nonspecific binding to the membrane. This conclusion was reinforced by studies of uptake at 4" C. When sodium gradient-dependent L-histidine uptake was studied at 4" C, maximum uptake was only 27.5% of that at 22" C (303.9 + 15.9 and 54.4 + 9.1 pmol.mg protein-'. 30 s-' at 22" C and 4" C, respectively; p < 0.05). As reported by others (3) (4) (5) (6) (7) (8) , all experiments characterizing L-histidine uptake were performed at 22" C.
Time course of L-histidine and L-glutamine transport.
Time-dependent uptake of L-histidine and L-glutamine are shown in Figure 1A and B. Uptake of amino acids was determined in the presence of either 100 mM sodium chloride or 100 mM choline chloride (control) in the incubation medium. The presence of an inward 100 mM sodium gradient stimulated the transport of both amino acids relative to 100 mM choline chloride. Uptake was rapid at the beginning, representing an "overshoot" phenomenon which peaked at 5-10 min and gradually approached equilibrium by 2 h, the last time point measured. Uptake in the absence of a sodium gradient was slow until it plateaued (Fig. I) . The final concentration of amino acids in the MMV was similar in the presence or absence of a sodium gradient, suggesting passive diffusion plus release of initially active transported substrate and eventual dissipation of the initial sodium gradient (6, 20) . At the peak of the "overshoot," the uptake of L-histidine and L-glutamine were about three times the final equilibrium value. These results imply that the inward sodium gradient stimulates movement of L-histidine into placental membrane vesicles. Silica thin-layer chromatography (isopropanol/l N HC1/H20; 65:15.6:18.4) showed lack of metabolism of the Lhistidine: after 2 h incubation with MMV, 95-100% of the label appeared at the same Rf (0.5) as the L-histidine standard.
Kinetic analysis of L-histidine uptake. The time course (Fig. 2 ) shows that initial sodium-dependent uptake of L-histidine is linear for more than 30 s. Therefore, concentration-dependent velocity of L-histidine uptake was determined at 30 s. The effect of different concentrations of L-histidine on the rate of amino acid uptake, in the absence and presence of sodium, is illustrated in Figure 2 . In the absence of sodium, the rate of uptake increased linearly with increasing L-histidine concentration throughout a range from 0.02-5 mM. In the presence of a sodium gradient, the relationship between L-histidine concentration and uptake was nonlinear and appeared saturable at low concentrations (approximately 0.5 mM). For higher L-histidine concentrations, uptake was linearly related to amino acid concentration in a pattern of simple diffusion.
To determine sodium gradient-dependent uptake kinetics, uptake in choline-containing medium was subtracted from uptake in the presence of sodium. A Lineweaver-Burk plot of the rate of the sodium-dependent uptake as a function of L-histidine concentration shows a linear relationship (Fig. 2, inset) . The results are consistent with uptake by a single transport system. The calculated uptake kinetic constants from five vesicle preparations were Km = 0.44 + 0.18 mM and V,,, = 536 f 94 nmol. mg protein-'. 30 s-'. These results are similar to those observed for proline in placental microvillous vesicles (4) .
Effect of cation and anion gradients on L-histidine transport.
To determine the specificity of L-histidine uptake for sodium stimulation, sodium was replaced with other cations (Table 1 and Fig. 3 ). L-histidine uptake was virtually abolished when the uptake medium contained only HTM solution. When the inwardly directed gradient of sodium was replaced by an inwardly directed gradient of choline, potassium, or cesium, the uptake of L-histidine was markedly reduced. Lithium, by contrast, gave results similar to sodium. The ability of lithium ion to substitute for sodium is a characteristic of system N in rat hepatocytes (1 I). Compared to no cation, the presence of an inward gradient of choline, potassium, and cesium did cause a modest stimulation in L-histidine uptake. This small stimulation could have been due to the presence of an anion. In fact, L-histidine uptake was reduced slightly (2 1 %) by the replacement of chloride with the relatively impermeable anion, sulfate. Substitution of chloride with the more permeable anion, gluconate, had no effect. These results suggest that the uptake of L-histidine is linked primarily to the inward sodium gradient, but there may be a modest anion influence. T p < 0.01 (ANOVA) relative to uptake in the presence of sodium chloride.
To further examine any specificity for the chloride anion, the effect of a chloride gradient on L-histidine uptake was determined using vesicles preloaded with either sodium gluconate or sodium sulfate. Under these conditions, there was no inward sodium gradient. Uptake of histidine was not stimulated by an inward chloride gradient. These results support the above conclusion that the inward sodium-gradient is the principal drive for Lhistidine into the vesicle.
In all studies testing for sodium-dependent uptake, 30-s uptake values with choline chloride (substituted for sodium chloride) were subtracted from uptake with sodium chloride, yielding the sodium-dependent component. Accordingly, when the concentration of sodium in the uptake medium was varied from 0-100 mM (differences in ion concentration were made up by choline to a final cation concentration of 100 mM), L-histidine transport into the intravesicular space increased linearly (Fig. 3) .
If L-histidine entry into the vesicle is coupled to sodium transport, factors which alter transmembrane movement of sodium should affect the rate of L-histidine uptake. Therefore, a negative intravesicular electrical potential was established with an outwardly directed potassium gluconate gradient in the presence of the potassium ionophore, valinomycin. Control uptake was determined in the presence of equimolar potassium gluconate on both sides of the membrane. Relative to control conditions, the presence of a negative intravesicle electrical potential stimulated both the initial rate and peak of the histidine uptake (uptake with outward potassium gradient = 18 1.3 + 9.7; control = 123.2 2 16.3 pmol. mg-' .30 s-I).
Effect ofN-ethylmaleimide on amino acid transport. A criterion
for distinguishing amino acid transport system A from other systems is differential sensitivity to N-ethylmaleimide (1 1). Certain transport function may depend, in part, upon functional thiol groups in the membrane camer proteins. Thiol-reactive reagents, such as N-ethylmaleimide, will inhibit D-glucose transport (2 1) and selected amino acid transport (1 1, 22) . Kilberg et al. (1 1) showed that N-ethylmaleimide inhibits rat hepatocyte system A by 76% but system N by only 26%. In our study, MeAIB uptake (system A) was inhibited by approximately 30%, whereas the uptake of L-histidine (system N), as well as L-cysteine (system ASC), and L-phenylalanine (system L), were not affected (Table 2) . Therefore, in human placental MMV, as in rat hepatocytes, the mechanism for L-histidine transport appears to be independent of thiol group inhibition.
Effect of pH on amino acid uptake. In differentiating various amino acid transport systems, the sensitivity of each system to changes in H' in the medium has been found to be valuable (1 1, 23, 24) . Therefore, we examined the uptake of MeAIB, L-cysteine, L-histidine, and L-phenylalanine at various H+ (Fig. 4) . The uptake of L-phenylalanine was not affected by changes in medium pH. Both MeAIB and L-histidine uptake were inhibited at either pH extremes. L-cysteine uptake was stimulated by * MMV were incubated for 60 min at 22°C in the presence or absence of 5 mM N-ethylmaleimide (7). The 30-min uptake assays were performed at 22°C. For L-cysteine uptake, 5 mM dithiothreitol was included in the incubation. The results are mean +-SD from six determinations. The rate for MeAIB, L-cysteine, and L-histidine are Na+-dependent rates; for L-phenylalanine, the uptake rate was observed in choline-containing medium. L-phenylalanine uptake in Na+-containing medium was not different from that in choline-containing medium.
f p < 0.01 (paired t-test) relative to control.
increasing H+ in the extravesicular medium such that it was highest at pH 6 and lowest at pH 8.5 . The correlation between L-cysteine uptake and H+, is thought to result from activation of the canier molecule by protonation (25) . The pH sensitivity pattern for L-histidine uptake distinguishes it from L-cysteine uptake, and hence, system ASC (23, 24) .
Inhibition of L-histidine by other sodium-dependent amino acids. To study the effects of different amino acids upon Lhistidine uptake, each potential inhibiting substrate was added at 1 mM. This is 10-fold greater than the L-histidine concentration. As shown in Table 3 , L-histidine uptake was not inhibited by MeAIB, transport of which is thought to be specific for system A. a-amino isobutyric acid, whose transport seems to overlap with many transport systems, has a modest inhibitory effect on L-histidine uptake. The results are similar to that reported in rat hepatocytes and further suggest an independent transport system for L-histidine. As expected, the greatest inhibition of L-histidine uptake occurred with L-histidine itself or L-glutamine, another amino acid with a nitrogen-containing side chain. The data presented for MeAIB, L-cysteine and L-histidine are rates for the sodium-dependent component only, with the rate in choline subtracted from the rate determined in sodium. There were no differences between the rate of uptake for L-phenylalanine in sodium or choline at any pH value. The uptake rate value at pH 7.5 for each amino acid are: MeAIB = 127.7 + 13.9; L-cysteine = 71.8 f 3.9; L-histidine = 103.7 + 6.0; and Lphenylalanine = 1 15.8 + 21.8 pmol. mg protein-'. 30 s-I. *p < 0.01 relative to uptake at pH 7.5 (ANOVA). *Uptake of 0.1 mM L-histidine by MMV were measured in the presence or absence of 1 mM inhibitor. The uptake was for 30 s at 22°C. Uptake was determined in the presence or absence of Na or choline. When L-cysteine was tested, 5 mM dithiothreitol was included in the medium. The data are for Na+-dependent fraction after subtracting uptake in choline. Results are averages from three-nine determinations.
Actual L-histidine uptake in the absence of inhibiting amino acid was 28 1. 
Inhibition of MeAIB and L-cysteine uptake by L-histidine.
The above results demonstrate that high concentrations of MeAIB and L-cysteine probably do not influence transport of L-histidine via its transport system. Alternatively, a high concentration of Lhistidine was tested against model amino acids for either system A or ASC, namely MeAIB or L-cysteine.
A Dixon plot of the results indicate that the uptake of MeAIB was inhibited by L-histidine but clearly not in a competitive manner. The plot appears to show noncompetitive inhibition (Fig. 5) . Similarly, the uptake of L-cysteine (Fig. 6 ) and serine (data not shown) were noncompetitively inhibited by L-histidine.
As L-histidine does not competitively inhibit MeAIB or Lcysteine uptake, it is unlikely that L-histidine is transported by either the A or ASC system. The results confirm experiments with N-ethylmaleimide and pH, indicating that uptake of Lhistidine occurs by a distinct transport mechanism. However, noncompetitive inhibition by L-histidine implies that there may be indirect interaction with the A and ASC transport systems, altering affinity or activity.
Inhibition of L-histidine uptake by L-glutamine.
To demonstrate that the placental system of L-histidine transport is shared by other amino acids which have nitrogen-containing side chains, the effect of varying concentrations of L-glutamine was studied. As shown by the Dixon plot in figure 7, L-histidine uptake was competitively inhibited by L-glutamine. Coupled with the simple (one concentration) inhibition of L-histidine uptake by L-glutamine, shown in Table 3 , these data provide evidence for the presence of a distinct carrier system for amino acids with a nitrogen-containing side chain.
To further demonstrate that L-histidine and L-glutamine occupy the same transport site, transstimulation of 3H-histidine uptake was assessed. Vesicles which were preloaded with either L-histidine or L-glutamine (100 pM) were used to measure sodium-stimulated L-histidine uptake. Preloading with L-histidine and L-glutamine increased L-histidine uptake by 184 f 6 and 21 3 -t 5%, respectively.
In summary, uptake of L-histidine by human placental MMV demonstrates characteristics similar to those described for system N in rat hepatocytes. Uptake is sodium dependent and stimulated by an electrical potential, but not inhibited by a model amino acid of the A system. There is a distinct pattern of pH sensitivity, and N-ethylmaleimide has no inhibitory effect. Finally, transport is competitively shared with L-glutamine, which also has a nitrogen-containing side chain.
The findings are the first demonstration of the putative system N in human tissue and may be added to the other amino acid transport systems described for the placenta (8, 26) . The human placenta is a readily available source of transport epithelium and may be a useful experimental resource for studies of human epithelial transport biology. L-HISTIDINE, rnM Fig. 6 . Dixon plot of L-hicysteine uptake inhibition by L-histidine. The uptake assay was performed as described in the legend of Figure 7 , except with 0, 0.1, 0.2, 0.5, and 1.0 mM L-histidine, and 5 mM dithiothreitol was included in the medium. L-GLUTAMINE, mM Fig. 7 . Dixon plot of L-histidine uptake inhibition by L-glutamine. The uptake assay was performed as described in the legend of Figure 5 except that 0.1, 0.2, and 0.5 mM 3H-~-histidine and 0, 0. I, 0.2, 0.5, and 1.0 mM L-glutamine were used.
